Institute for Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University Vienna, Vienna, Austria.
Institute for Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University Vienna, Vienna, Austria.
Curr Opin Biotechnol. 2023 Oct;83:102984. doi: 10.1016/j.copbio.2023.102984. Epub 2023 Aug 10.
Macrophages within the tumor microenvironment of solid tumors and metastasis are heterogeneous populations, which contribute to diverse steps of tumorigenesis. Tumor-associated macrophages (TAMs) can either derive from circulation-derived monocytes or tissue-resident macrophages (TRMs). In health, TRMs populate the majority of tissues, orchestrating critical homeostatic and reparative functions. While TRM-specific functions in tumor initiation and progression remain unclear, recent studies have revealed that TRMs are a significant source of TAMs in both mouse and human cancers, where they closely resemble gene signatures of their normal, organ-specific TRM counterparts. In this review, we highlight recent advances toward systematically understanding the role of TRMs as an important TAM subset and opportunities how this macrophage population could be exploited for therapeutical targeting strategies.
实体瘤和转移瘤的肿瘤微环境中的巨噬细胞是异质群体,它们有助于肿瘤发生的多个步骤。肿瘤相关巨噬细胞(TAMs)可以来源于循环衍生的单核细胞或组织驻留巨噬细胞(TRMs)。在健康状态下,TRMs 存在于大多数组织中,协调关键的稳态和修复功能。虽然 TRM 在肿瘤起始和进展中的特定功能尚不清楚,但最近的研究表明,TRMs 是小鼠和人类癌症中 TAMs 的重要来源,在这些癌症中,它们与正常、器官特异性 TRM 对应物的基因特征非常相似。在这篇综述中,我们强调了最近在系统理解 TRMs 作为重要 TAM 亚群的作用方面的进展,以及如何利用这种巨噬细胞群体来开发治疗性靶向策略的机会。